Cardiology

Lower risk for heart failure with new type 2 diabetes drug

The new drug type for type 2 diabetes, SGLT2 inhibitors, are associated with a reduced risk of heart failure and death, as well as of major cardiovascular events, a major Scandinavian registry study led from Karolinska Institutet ...

Medications

Dipeptidyl peptidase-4 inhibitors may up pancreatic disease risk

(HealthDay)—Use of dipeptidyl peptidase-4 inhibitors (DPP-4i) is associated with increased risks for pancreatitis and pancreatic cancer in patients with newly diagnosed type 2 diabetes, according to a study published online ...

page 1 from 23